Deze pagina is automatisch vertaald en de nauwkeurigheid van de vertaling kan niet worden gegarandeerd. Raadpleeg de Engelse versie voor een brontekst.

Surgical Treatment of Adjacent Segment Stenosis (STASS)

18 juni 2026 bijgewerkt door: Anton Früh, Charite University, Berlin, Germany

The goal of this clinical trial is to learn whether microdecompression alone is as effective as decompression with extension of fusion surgery in patients with symptomatic adjacent segment stenosis after previous lumbar fusion surgery.

The main questions it aims to answer are:

Is microdecompression alone non-inferior to decompression with extension of fusion in improving disability 24 months after surgery, as measured by the Oswestry Disability Index (ODI)? Does microdecompression alone result in similar or lower rates of complications, reoperations, pain, and radiological progression compared with decompression and fusion?

Researchers will compare microdecompression alone to decompression with extension of lumbar fusion to determine whether the less invasive procedure can achieve similar clinical outcomes while reducing surgical burden and preserving spinal structures.

Participants will:

Be randomly assigned to one of two treatment groups: microdecompression alone or decompression with extension of lumbar fusion.

Undergo the assigned surgical treatment. Attend clinical and radiological follow-up visits at 6, 12, and 24 months after surgery.

Complete questionnaires assessing disability, pain, quality of life, sleep quality, and mental health.

Undergo routine imaging and clinical examinations to evaluate treatment outcomes and possible complications.

Studie Overzicht

Toestand

Nog niet aan het werven

Conditie

Interventie / Behandeling

Studietype

Ingrijpend

Inschrijving (Geschat)

338

Fase

  • Niet toepasbaar

Contacten en locaties

In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.

Studiecontact

Studie Locaties

  • Duitsland
    • State of Berlin
      • Berlin, State of Berlin, Duitsland, 10117
        • Charité - Universitätsmedizin Berlin

Deelname Criteria

Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.

Geschiktheidscriteria

Leeftijden die in aanmerking komen voor studie

  • Volwassen
  • Oudere volwassene

Accepteert gezonde vrijwilligers

Nee

Beschrijving

Inclusion Criteria:

  • Age ≥18 years.
  • Oswestry Disability Index (ODI) between 30% and 80% at screening.
  • Symptomatic adjacent segment stenosis following degenerative lumbar fusion surgery.
  • Persistent symptoms despite at least 6 weeks of appropriate conservative treatment.
  • Radiological evidence of adjacent segment spinal stenosis on magnetic resonance imaging (MRI).
  • Ability to understand the study procedures and complete patient-reported outcome questionnaires.
  • Ability to provide written informed consent.

Exclusion Criteria:

  • Adjacent segment kyphosis or scoliosis greater than 10 degrees.
  • Screw loosening or pseudarthrosis of the previous fusion construct.
  • Known current pregnancy or breastfeeding.
  • Acute traumatic spinal injury or fracture.
  • Active inflammatory disease of the spine.
  • Active neoplastic disease of the spine.
  • Contraindication to spinal surgery.
  • Inability to provide informed consent or complete study questionnaires.
  • Symptoms attributable to spinal stenosis are not the predominant clinical complaint
  • Foraminal stenosis grade ≥2 according to the Lee classification.
  • Dynamic spondylolisthesis ≥3 mm on flexion-extension radiographs.
  • Persons involuntarily detained by judicial or administrative order.

Studie plan

Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.

Hoe is de studie opgezet?

Ontwerpdetails

  • Primair doel: Behandeling
  • Toewijzing: Gerandomiseerd
  • Interventioneel model: Parallelle opdracht
  • Masker: Enkel

Wapens en interventies

Deelnemersgroep / Arm
Interventie / Behandeling
Actieve vergelijker: Control
Decompression and fusion
Procedure: Microsurgical Decompression with Extension of Fusion
Participants undergo microsurgical decompression of symptomatic adjacent segment stenosis combined with extension of the existing lumbar fusion.
Actieve vergelijker: Intervention
Mircosurgical decompression only
Procedure: Microsurgical Decompression Alone
Participants undergo microsurgical decompression of symptomatic adjacent segment stenosis after previous lumbar fusion surgery without extension of the existing fusion.

Wat meet het onderzoek?

Primaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Proportion of Participants Achieving at Least 30% Reduction in Oswestry Disability Index (ODI)
Tijdsspanne: 24 months after surgery
The primary endpoint is the proportion of participants achieving a reduction of at least 30% in the Oswestry Disability Index (ODI) compared with baseline. The ODI is a validated patient-reported outcome measure assessing disability related to lumbar spine disorders on a scale from 0% to 100%. A reduction of at least 30% is considered clinically meaningful.
24 months after surgery

Secundaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Pain related disability
Tijdsspanne: Baseline (before surgery), 6 months after surgery, 12 months after surgery, and 24 months after surgery.
Disability related to low back pain assessed using the Oswestry Disability Index (ODI). The ODI score ranges from 0 to 100%, with higher scores indicating greater disability and worse functional impairment.
Baseline (before surgery), 6 months after surgery, 12 months after surgery, and 24 months after surgery.
Leg Pain Intensity at Rest
Tijdsspanne: Baseline (before surgery), 6 months after surgery, 12 months after surgery, and 24 months after surgery.
Pain intensity assessed using the Numeric Rating Scale (NRS; 0-10) for leg pain at rest.The NRS ranges from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain. Higher scores indicate greater pain intensity.
Baseline (before surgery), 6 months after surgery, 12 months after surgery, and 24 months after surgery.
Leg Pain Intensity during Movement
Tijdsspanne: Baseline (before surgery), 6 months after surgery, 12 months after surgery, and 24 months after surgery.
Pain intensity assessed using the Numeric Rating Scale (NRS; 0-10) for leg pain during movement.The NRS ranges from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain. Higher scores indicate greater pain intensity.
Baseline (before surgery), 6 months after surgery, 12 months after surgery, and 24 months after surgery.
Back Pain Intensity at Rest
Tijdsspanne: Baseline (before surgery), 6 months after surgery, 12 months after surgery, and 24 months after surgery.
Pain intensity assessed using the Numeric Rating Scale (NRS; 0-10) for back pain at rest.The NRS ranges from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain. Higher scores indicate greater pain intensity.
Baseline (before surgery), 6 months after surgery, 12 months after surgery, and 24 months after surgery.
Back Pain Intensity during Movement
Tijdsspanne: Baseline (before surgery), 6 months after surgery, 12 months after surgery, and 24 months after surgery.
Pain intensity assessed using the Numeric Rating Scale (NRS; 0-10) for back pain during movement.The NRS ranges from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain. Higher scores indicate greater pain intensity.
Baseline (before surgery), 6 months after surgery, 12 months after surgery, and 24 months after surgery.
Maximum Walking Distance
Tijdsspanne: Baseline (before surgery), 6 months after surgery, 12 months after surgery, and 24 months after surgery.
Maximum walking distance measured in meters.
Baseline (before surgery), 6 months after surgery, 12 months after surgery, and 24 months after surgery.
Health-Related Quality of Life Assessed by the 36-Item Short Form Health Survey (SF-36)
Tijdsspanne: Baseline (before surgery), 6 months after surgery, 12 months after surgery, and 24 months after surgery.
generates eight domain scores (physical functioning, role limitations due to physical health, bodily pain, general health perceptions, vitality, social functioning, role limitations due to emotional problems, and mental health), each transformed to a scale ranging from 0 to 100, with higher scores indicating better health-related quality of life and functional status. Unit of Measure: Points on a scale (0-100).
Baseline (before surgery), 6 months after surgery, 12 months after surgery, and 24 months after surgery.
Health-Related Quality of Life Assessed by the EuroQol 5-Dimension 5-Level Questionnaire (EQ-5D-5L) Index Score
Tijdsspanne: Baseline (before surgery), 6 months after surgery, 12 months after surgery, and 24 months after surgery.
Health-related quality of life assessed using the EuroQol 5-Dimension 5-Level questionnaire (EQ-5D-5L). The EQ-5D-5L evaluates five dimensions of health status (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression), each with five response levels. Responses are converted into a single EQ-5D-5L Index Score using an established country-specific value set. Higher index scores indicate better health-related quality of life. Unit of Measure: Utility index score (higher scores indicate better health-related quality of life).
Baseline (before surgery), 6 months after surgery, 12 months after surgery, and 24 months after surgery.
Mood Assessed by the German General Depression Scale - Short Form (ADS-K)
Tijdsspanne: Baseline (before surgery), 6 months after surgery, 12 months after surgery, and 24 months after surgery.
Depressive symptoms assessed using the German General Depression Scale - Short Form (ADS-K). The ADS-K is a self-report questionnaire comprising 15 items, each rated on a 4-point Likert scale (0-3 points). Total scores range from 0 to 45 points, with higher scores indicating more severe depressive symptomatology and worse mood status. Unit of Measure: Points on a scale (range: 0-45; higher scores indicate more severe depressive symptoms)
Baseline (before surgery), 6 months after surgery, 12 months after surgery, and 24 months after surgery.
Sleep Quality Assessed by the Pittsburgh Sleep Quality Index (PSQI)
Tijdsspanne: Baseline (before surgery), 6 months after surgery, 12 months after surgery, and 24 months after surgery.
Sleep quality assessed using the Pittsburgh Sleep Quality Index (PSQI). The PSQI is a self-administered questionnaire evaluating sleep quality and disturbances over the previous month across seven domains: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleeping medication, and daytime dysfunction. Component scores are summed to generate a global PSQI score ranging from 0 to 21 points, with higher scores indicating poorer sleep quality and greater sleep disturbance. Unit of Measure: Points on a scale (range: 0-21; higher scores indicate worse sleep quality).
Baseline (before surgery), 6 months after surgery, 12 months after surgery, and 24 months after surgery.
Length of hospital stay
Tijdsspanne: From date of surgery until hospital discharge, up to 30 days postoperatively
Length of hospital stay measured in days from surgery until hospital discharge.
From date of surgery until hospital discharge, up to 30 days postoperatively
Intensive Care Unit Stay
Tijdsspanne: From admission to the intensive care unit after surgery until discharge from the intensive care unit, up to 30 days postoperatively.
Duration of intensive care unit stay measured in days.
From admission to the intensive care unit after surgery until discharge from the intensive care unit, up to 30 days postoperatively.
Additional or Revision Spine Surgery
Tijdsspanne: Up to 24 months after surgery
Proportion of participants requiring additional spinal surgery or revision surgery during follow-up.
Up to 24 months after surgery
Perioperative Complications
Tijdsspanne: Perioperative/Periprocedural
Number and type of perioperative complications associated with the surgical procedure.
Perioperative/Periprocedural
Operative Parameters
Tijdsspanne: Perioperative/Periprocedural
Operative duration, intraoperative blood loss
Perioperative/Periprocedural
Dynamic Spondylolisthesis
Tijdsspanne: 24 month after surgery
Presence of dynamic spondylolisthesis defined as a translation of ≥3 mm on flexion-extension radiographs.Unit of Measure: Participants with dynamic spondylolisthesis.
24 month after surgery
Central Stenosis Severity Assessed by the Schizas Classification
Tijdsspanne: 24 months after surgery
Central canal stenosis at the adjacent segment assessed on MRI using the Schizas classification (Grades A-D).Unit of Measure: Grade (A-D; higher grades indicate more severe stenosis).
24 months after surgery
Foraminal Stenosis Severity Assessed by the Lee Classification
Tijdsspanne: 24 months after surgery.
Foraminal stenosis at the adjacent segment assessed on MRI using the Lee classification (Grades 1-4).Unit of Measure: Grade (1-4; higher grades indicate more severe foraminal stenosis).
24 months after surgery.
Implant Integrity
Tijdsspanne: 24 months after surgery.
Implant integrity assessed on radiographs, including evidence of implant loosening, breakage, or material dislocation.Unit of Measure: Participants with implant failure.
24 months after surgery.
Segmental Lordosis
Tijdsspanne: 24 months after surgery.
Segmental lordosis measured on standing lateral radiographs.Unit of Measure: Degrees (°).
24 months after surgery.

Medewerkers en onderzoekers

Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.

Sponsor

Charite University, Berlin, Germany

Studie record data

Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.

Bestudeer belangrijke data

Studie start (Geschat)

1 oktober 2026

Primaire voltooiing (Geschat)

30 september 2030

Studie voltooiing (Geschat)

1 maart 2031

Studieregistratiedata

Eerst ingediend

29 mei 2026

Eerst ingediend dat voldeed aan de QC-criteria

18 juni 2026

Eerst geplaatst (Werkelijk)

22 juni 2026

Updates van studierecords

Laatste update geplaatst (Werkelijk)

22 juni 2026

Laatste update ingediend die voldeed aan QC-criteria

18 juni 2026

Laatst geverifieerd

1 juni 2026

Meer informatie

Termen gerelateerd aan deze studie

Trefwoorden

Aanvullende relevante MeSH-voorwaarden

Andere studie-ID-nummers

  • STASS-Trial
  • 574896382 (Ander subsidie-/financieringsnummer: Deutsche Forschungsgemeinschaft (DFG))

Plan Individuele Deelnemersgegevens (IPD)

Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?

JA

Beschrijving IPD-plan

Individual participant data underlying the results reported in publications arising from this study, after de-identification, will be made available upon reasonable request to the corresponding investigator.

Supporting documents including the study protocol, statistical analysis plan, and data dictionary will also be made available.

IPD-tijdsbestek voor delen

Beginning 12 months following publication of the primary study results and ending 5 years after publication.

IPD-toegangscriteria voor delen

De-identified individual participant data (IPD) underlying the results reported in publications arising from this study, as well as the study protocol, statistical analysis plan, and analytic code, will be made available to qualified researchers.

Access will be granted to investigators who provide a scientifically sound research proposal that is approved by the study steering committee. Requests must be submitted to the study sponsor and should specify the intended use of the data.

Data will be shared only after publication of the primary study results and following execution of an appropriate data-sharing agreement. Access will be provided through a secure electronic data transfer system in accordance with applicable data protection regulations.

IPD delen Ondersteunend informatietype

  • LEERPROTOCOOL
  • SAP
  • ANALYTIC_CODE

Informatie over medicijnen en apparaten, studiedocumenten

Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel

Nee

Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct

Nee

Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .

Abonneren